Nov 4, 2024 | Business News, Industry Talk
My time at MEDICA 2022 Posted on December 9, 2022 By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the privilege of not only attending but presenting at MEDICA, the world’s largest event for the medical sector. It’s so inspiring...
Nov 4, 2024 | Business News, Investor News
Development Bank of Wales ramping up tech equity deals since the lockdown Posted on September 12, 2022 The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most promising tech-focused start-ups over a ten week period since the pandemic...
Nov 4, 2024 | Business News, Milestones
Reacta Healthcare secures first US patent Posted on August 8, 2022 The patent has been granted for challenge meals, which are used in oral food challenges (OFCs). Unique to the Reacta formulation is Reacta’s ability to create a non-allergen formulation that is...
Nov 4, 2024 | Business News, Investor News
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm Posted on July 14, 2021 Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a business that is on course to transform the food allergy diagnostics market....
Nov 4, 2024 | Business News, Milestones
UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA GMP licence Posted on June 16, 2021 Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an MHRA site license This license opens up significant opportunities for the companies...
Nov 4, 2024 | Business News, Milestones
Reacta Biotech making progress on peanut diagnostic product Posted on May 19, 2020 Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic product within the next two years as global activity to treat peanut allergies...
